Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan Trough/Peak Effects in Chinese Hypertension
NCT02206659Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2000
- Primary completion
- Feb 2001
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of telmisartan in essential hypertension, sponsored by Boehringer Ingelheim. Started Aug 2000; status: completed.
02
Drugs
telmisartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02206659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02206659.